BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15308098)

  • 1. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
    Jeon MS; Atfield A; Venuprasad K; Krawczyk C; Sarao R; Elly C; Yang C; Arya S; Bachmaier K; Su L; Bouchard D; Jones R; Gronski M; Ohashi P; Wada T; Bloom D; Fathman CG; Liu YC; Penninger JM
    Immunity; 2004 Aug; 21(2):167-77. PubMed ID: 15308098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
    Loeser S; Penninger JM
    Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
    Schmitz ML
    Sci Signal; 2009 Jun; 2(76):pe38. PubMed ID: 19549983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
    Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
    J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
    St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
    J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
    Bachmaier K; Krawczyk C; Kozieradzki I; Kong YY; Sasaki T; Oliveira-dos-Santos A; Mariathasan S; Bouchard D; Wakeham A; Itie A; Le J; Ohashi PS; Sarosi I; Nishina H; Lipkowitz S; Penninger JM
    Nature; 2000 Jan; 403(6766):211-6. PubMed ID: 10646608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
    Nguyen TTT; Wang ZE; Shen L; Schroeder A; Eckalbar W; Weiss A
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33974042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 ubiquitin ligases as T cell anergy factors.
    Mueller DL
    Nat Immunol; 2004 Sep; 5(9):883-90. PubMed ID: 15334084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
    Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
    J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
    Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
    Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.
    Heissmeyer V; Macián F; Im SH; Varma R; Feske S; Venuprasad K; Gu H; Liu YC; Dustin ML; Rao A
    Nat Immunol; 2004 Mar; 5(3):255-65. PubMed ID: 14973438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
    Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
    Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
    J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Egr-2 and Egr-3 are negative regulators of T cell activation.
    Safford M; Collins S; Lutz MA; Allen A; Huang CT; Kowalski J; Blackford A; Horton MR; Drake C; Schwartz RH; Powell JD
    Nat Immunol; 2005 May; 6(5):472-80. PubMed ID: 15834410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
    Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
    J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-b regulates the CD28 dependence of T-cell activation.
    Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
    Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
    Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
    J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
    Sohn HW; Gu H; Pierce SK
    J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.
    Hsu TS; Hsiao HW; Wu PJ; Liu WH; Lai MZ
    J Immunol; 2014 Aug; 193(4):1672-80. PubMed ID: 25000980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
    Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
    Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.